AlphaMadera
Strata Critical Medical, Inc. (SRTA)
$6.05
+0.12 (+2.16%)Delayed quote.
Price history
Daily close- Start
- $4.85
- Latest close
- $6.05
- Period change
- +24.74%
- Period low
- $4.03
- Period high
- $6.47
Key metrics
- Market cap
- $502.49M
- Volume
- 49.4K
- Average volume
- 989.6K
- 52-week range
- $3.95 – $6.50
- Beta
- 2.56
- Last dividend
- —
- EPS (TTM)
- -$0.29
- P/E ratio
- 9.62
- Revenue (TTM)
- $280.76M
- Net income (TTM)
- -$24.81M
- Total assets
- $328.88M
- Total debt
- $3.62M
- Cash and equivalents
- $35.14M
Key financials (trailing twelve months).
Company profile
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NASDAQ
- CEO
- Melissa Tomkiel
- Employees
- 327
- Headquarters
- New York, NY, US
- IPO date
- 2019-11-05
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $197.14M | $248.69M | $225.18M |
| Gross profit | $41.13M | $58.92M | $42.12M |
| Operating income | -$22.35M | -$33.93M | -$68.12M |
| EBITDA | -$5.71M | -$21.60M | -$50.43M |
| Net income | $41.35M | -$27.31M | -$56.08M |
| Diluted EPS | $0.50 | -$0.35 | -$0.76 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $30.97M | $18.38M | $27.87M |
| Total assets | $325.47M | $256.68M | $294.94M |
| Total liabilities | $46.40M | $34.74M | $60.64M |
| Total debt | $3.31M | $9.32M | $24.52M |
| Shareholders’ equity | $279.07M | $221.94M | $234.30M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | -$48.91M | -$2.52M | -$32.35M |
| Capital expenditure | -$11.01M | -$32.99M | -$2.11M |
| Free cash flow | -$59.92M | -$35.51M | -$34.46M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $74.08M | $72.51M | $67.38M | $66.79M | $49.30M | $70.80M |
| Gross profit | $16.82M | $15.21M | $14.12M | $11.67M | $11.61M | $17.74M |
| Operating income | -$3.83M | -$5.41M | -$2.97M | -$6.41M | -$5.62M | -$4.95M |
| EBITDA | -$7.62M | -$2.00M | $1.16M | -$558.0K | -$7.95M | -$1.95M |
| Net income | -$7.62M | -$10.52M | $2.15M | -$8.83M | $57.42M | -$3.74M |
| Diluted EPS | -$0.09 | -$0.12 | $0.03 | -$0.11 | $0.70 | -$0.05 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $35.14M | $16.32M | $58.72M | $30.97M | $22.75M | $58.75M |
| Total assets | $328.88M | $332.70M | $327.62M | $325.47M | $335.08M | $257.92M |
| Total liabilities | $52.51M | $53.38M | $41.89M | $46.40M | $52.08M | $34.82M |
| Total debt | $3.62M | $4.25M | $4.47M | $3.31M | $3.47M | $8.84M |
| Shareholders’ equity | $276.38M | $279.32M | $285.73M | $279.07M | $283.00M | $223.10M |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.46M | $5.69M | $3.56M | -$8.31M | -$31.84M | -$3.06M |
| Capital expenditure | -$400.0K | -$2.19M | -$5.48M | -$2.00M | -$3.13M | -$2.73M |
| Free cash flow | $9.06M | $3.50M | -$1.93M | -$10.31M | -$34.97M | -$5.80M |